Copolymer liquid embolization of dural arteriovenous fistulas: A 20-year single-center experience
Jazyk angličtina Země Spojené státy americké Médium print-electronic
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
37602898
DOI
10.1111/jon.13148
Knihovny.cz E-zdroje
- Klíčová slova
- Onyx, dural arteriovenous fistulas, endovascular treatment, transarterial embolization,
- MeSH
- cévní malformace centrálního nervového systému * diagnostické zobrazování terapie MeSH
- lidé MeSH
- píštěle * farmakoterapie MeSH
- polyvinyly terapeutické užití MeSH
- retrospektivní studie MeSH
- terapeutická embolizace * metody MeSH
- výsledek terapie MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- polyvinyly MeSH
BACKGROUND AND PURPOSE: Dural arteriovenous fistulas (DAVFs) with cortical venous drainage (CVD) carry significant risks of cerebral ischemia and intracranial hemorrhage. Endovascular treatment (EVT) using Onyx, a copolymer-based liquid embolic material, has become the preferred approach. However, the optimal treatment strategy for anterior cranial fossa DAVFs remains debated. METHODS: This retrospective study analyzed outcomes of EVT for DAVFs in a single center from 2002 to 2023. Patient data including demographics, clinical status, angiographic findings, embolization techniques, and outcomes were recorded. The results of the anterior fossa malformations were analyzed separately afterward. RESULTS: A total of 195 DAVFs were included in the study. The most common presenting symptom was hemorrhage (41%), most fistulas were located in the transverse and sigmoid sinus region (48%), and the majority of DAVFs had direct CVD (78%). Transarterial embolization with Onyx was the preferred treatment strategy in majority of cases (92%). Overall, 94% of patients showed improvement or stability on the modified Rankin Scale. Two patients died due to rebleeding after partial DAVF embolization. Onyx demonstrated higher immediate complete occlusion rate compared to other embolic materials (88% vs. 35%). Overall, 91% of fistulas were closed at the last follow-up. Ten anterior fossa DAVFs were treated, resulting in clinical improvement and complete occlusion in all cases. CONCLUSION: Based on the results of our study, we believe that a cure of DAVFs, including those in the anterior fossa, can be achieved in more than 90% of cases through transarterial Onyx embolization, given long-term clinical experience.
Zobrazit více v PubMed
Borden JA, Wu JK, Shucart WA. A proposed classification for spinal and cranial dural arteriovenous fistulous malformations and implications for treatment. J Neurosurg. 1995;82:166-79.
Gross BA, Du R. The natural history of cerebral dural. Neurosurgery. 2012;71:594-603.
Gross BA, Albuquerque FC, Moon K, et al. Evolution of treatment and a detailed analysis of occlusion, recurrence, and clinical outcomes in an endovascular library of 260 dural arteriovenous fistulas. J Neurosurg. 2016;126:1884-93.
Gross BA, Albuquerque FC, Mcdougall CG, et al. A multi-institutional analysis of the untreated course of cerebral dural arteriovenous fistulas. J Neurosurg. 2017;129:1114-9.
Sadeh-Gonike U, Magand N, Armoiry X, et al. Transarterial onyx embolization of intracranial dural fistulas: a prospective cohort, systematic review, and meta-analysis. Neurosurgery. 2018;82:854-63.
Johnson CS, Chiu A, Cheung A, et al. Embolization of cranial dural arteriovenous fistulas in the liquid embolic era: a Sydney experience. J Clin Neurosci. 2017;49:62-70.
Natarajan SK, Ghodke B, Kim LJ, et al. Multimodality treatment of intracranial dural arteriovenous fistulas in the onyx era: a single center experience. World Neurosurg. 2010;73:365-79.
Ghobrial GM, Marchan E, Nair AK, et al. Cerebrovascular dural arteriovenous fistulas: a review of the literature and a presentation of a single institutions experience. World Neurosurg. 2012;80:94-102.
Oh SH, Choi JH, Kim B, et al. Treatment outcomes according to various treatment modalities for intracranial dural arteriovenous fistulas in the onyx era: a 10-year single-center experience. World Neurosurg. 2019;126:825-34.
Rangel-Castilla L, Barber SM, Klucznik R, et al. Mid and long term outcomes of dural arteriovenous fistula endovascular management with Onyx. Experience of a single tertiary center. J Neurointerv Surg. 2014;6:607-13.
Ambekar S, Gaynor BG, Peterson EC, et al. Long-term angiographic results of endovascularly ‘cured’ intracranial dural arteriovenous fistulas. J Neurosurg. 2016;124:1123-7.
Voldrich R, Netuka D, Charvat F, et al. Long-term stability of Onyx: is there any indication for repeated angiography after dural arteriovenous fistula embolization? J Neurosurg. 2022;136:175-84.
Choo DM, Shankar JJS. Onyx versus nBCA and coils in the treatment of intracranial dural arteriovenous fistulas. Interventional Neuroradiology. 2016;22:212-6.
McConnell KA, Tjoumakaris SI, Allen J, et al. Neuroendovascular management of dural arteriovenous malformations. Neurosurg Clin N Am. 2009;20:431-9.
Kakarla UK, Deshmukh VR, Zabramski JM, et al. Surgical treatment of high-risk intracranial dural arteriovenous fistulae: clinical outcomes and avoidance of complications. Neurosurgery. 2007;61:447-9.
Kawaguchi S, Sasaki T. Surgical treatment of intrarcranial dural arteriovenous fistulas. Brain and Nerve. 2008;60:897-900.
Albright AL, Latchaw RE, Prince RA. Posterior dural arteriovenous malformations in infancy. Neurosurgery. 1983;13:129-35.
Djindjian R, Merland JJ, Rey A, et al. Super-selective arteriography of the external carotid artery. Importance of this new technic in neurological diagnosis and in embolization. Neurochirurgie. 1973:165-71.
Cognard C, Gobin YP, Pierot L, et al. Cerebral dural arteriovenous fistulas: clinical and angiographic correlation with a revised classification of venous drainage. Radiology. 1995;194:671-80.
Byrne JV. Tutorials in endovascular neurosurgery and interventional neuroradiology. 2nd ed. Berlin, Germany: Springer; 2012.
Hu YC, Newman CB, Dashti SR, et al. Cranial dural arteriovenous fistula: transarterial Onyx embolization experience and technical nuances. J Neurointerv Surg. 2010;3:5-13.
Moenninghoff C, Pohl E, Deuschl C, et al. Outcomes after onyx embolization as primary treatment for cranial dural arteriovenous fistula in the past. Acad Radiol. 2019;27:123-31.
Rabinov JD, Yoo AJ, Ogilvy CS, et al. Onyx versus n-BCA for embolization of cranial dural arteriovenous fistulas. J Neurointerv Surg. 2013;5:306-10.
Chandra RV, Leslie-Mazwi TM, Mehta BP, et al. Transarterial Onyx embolization of cranial dural arteriovenous fistulas: long-term follow-up. Am J Neuroradiol. 2014;35:1793-7.
Luo C-B, Chang F-C, Mu-Huo Teng M, et al. Transarterial Onyx embolization of intracranial dural arteriovenous fistulas: a single center experience. J Chin Med Assoc. 2014;77:184-9.
Dabus G, Kan P, Diaz C, et al. Endovascular treatment of anterior cranial fossa dural arteriovenous fistula: a multicenter series. Neuroradiology. 2021;63:259-66.
Kobayashi A, Salman RA. Review Prognosis and treatment of intracranial dural arteriovenous fistulae: a systematic review and meta-analysis. Int J Stroke. 2014;9:670-7.
Xu K, Ji T, Li C, et al. Current status of endovascular treatment for dural arteriovenous fistulae in the anterior cranial fossa: a systematic literature review. Int J Med Sci. 2019;16:203-11.
Agid R, TerBrugge K, Rodesch G, et al. Management strategies for anterior cranial fossa (ethmoidal) dural arteriovenous fistulas with an emphasis on endovascular treatment. J Neurosurg. 2009;110:79-84.
Lv X, Li Y, Wu Z. Endovascular treatment of anterior cranial fossa dural arteriovenous fistula. Neuroradiology. 2008;50:433-7.